Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2024-09-02 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于回购股份进展的公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from a company about the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with regulatory guidelines. It does not contain financial statements or detailed financial analysis but reports on the status of a share buyback plan. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares. The document length is short and focused solely on the repurchase progress, not a full financial report or announcement of a report publication.
2024-09-02 Chinese
关于董事会、监事会换届完成暨部分董事、高级管理人员届满离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about the completion of the board of directors and supervisory board re-election, as well as the departure of some directors and senior management due to term expiration. It details the composition of the new board and management, qualifications, and contact information. There are no financial statements or detailed financial data present. The document is clearly about changes in the company's board and senior management, matching the description of 'Board/Management Information (MANG)'. The document length is short (1871 characters), and it is not an announcement of a report publication but a substantive announcement about management changes.
2024-08-14 Chinese
2024年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and compliance of the procedures and results of a company's 2024 second extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholder meeting. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its resolutions. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes and related shareholder meeting details.
2024-08-14 Chinese
第四届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the fourth board of directors of the company, including election of the chairman, appointment of senior management, and committee members. It includes biographies of the appointed directors and senior executives. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and management changes and appointments. Therefore, this document fits the category of Board/Management Information (MANG). The document length is about 5955 characters, which is sufficient for a full announcement rather than a brief notice.
2024-08-14 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2024 second extraordinary shareholders' meeting of Xiamen Aide Biomedical Technology Co., Ltd. It includes voting results on various proposals such as changes in registered capital, board member elections, and remuneration. The document specifies the meeting date, voting methods, attendance, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is about 5285 characters, which is sufficient for a full voting results announcement rather than a brief notice or report publication announcement.
2024-08-14 Chinese
第四届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the first meeting of the fourth Supervisory Board of Xiamen Aide Bio-Pharmaceutical Technology Co., Ltd. It details the meeting's convening, attendance, and voting results, including the election of the Supervisory Board Chairman. There is no financial data, audit information, or report content. The document is an official announcement related to board/management changes, specifically concerning the Supervisory Board. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on governance matters, not a full report or financial disclosure.
2024-08-14 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.